Anthony T.�C. Chan

Active 1993–2025

155
Papers
33,743
Citations
105
h-index
154
i10-index

Citations

Citations per year for Anthony T.�C. Chan1987: 2 citations1994: 1 citations1996: 4 citations1997: 9 citations1998: 7 citations1999: 11 citations2000: 36 citations2001: 62 citations2002: 90 citations2003: 67 citations2004: 142 citations2005: 142 citations2006: 129 citations2007: 132 citations2008: 227 citations2009: 125 citations2010: 233 citations2011: 200 citations2012: 249 citations2013: 228 citations2014: 217 citations2015: 287 citations2016: 170 citations2017: 259 citations2018: 260 citations2019: 1,212 citations2020: 1,182 citations2021: 1,231 citations2022: 851 citations2023: 671 citations2024: 1,078 citations2025: 468 citations2026: 15 citations1988–1993: no citations, so these years are not shown1995: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 2,702 citing papers, 29.2% of this breakdownUnited States: 1,653 citing papers, 17.8% of this breakdownHong Kong: 524 citing papers, 5.6% of this breakdownUnited Kingdom: 381 citing papers, 4.1% of this breakdownGermany: 311 citing papers, 3.4% of this breakdownItaly: 276 citing papers, 3% of this breakdownJapan: 265 citing papers, 2.9% of this breakdownFrance: 253 citing papers, 2.7% of this breakdownTaiwan: 248 citing papers, 2.7% of this breakdownCanada: 245 citing papers, 2.6% of this breakdownSingapore: 191 citing papers, 2.1% of this breakdownAustralia: 186 citing papers, 2% of this breakdown
0%29.2%Other 21.9%

Fields

  • Medicine61.3%
  • Biochemistry, Genetics and Molecular Biology32%
  • Immunology and Microbiology2.3%
  • Chemistry0.9%
  • Physics and Astronomy0.6%
  • Engineering0.5%
  • Other2.4%

Topics

  • Head and Neck Cancer Studies9.4%
  • Cancer Genomics and Diagnostics3.8%
  • Viral-associated cancers and disorders3.7%
  • Head and Neck Surgical Oncology2.9%
  • Hepatocellular Carcinoma Treatment and Prognosis2.7%
  • Epigenetics and DNA Methylation2.7%
  • Other74.8%

Coauthors

All papers

Open in search
  1. Nasopharyngeal carcinoma

    Authors: , , , , , - The Lancet 2019 cited by 3,065

  2. Nasopharyngeal carcinoma: an evolving paradigm

    Authors: , , , , , , , , , , , - Nature Reviews Clinical Oncology 2021 cited by 523

  3. Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 779

  4. Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

    Authors: , , , , , , , , , , , , , - Annals of Oncology 2020 cited by 424

  5. Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 391

  6. Nasopharyngeal carcinoma

    Authors: , , , - The Lancet 2015 cited by 1,262

  7. Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing

    Authors: , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 466

  8. Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective

    Authors: , , , - Journal of Clinical Oncology 2015 cited by 845

  9. Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2023 cited by 89

  10. Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 cited by 466

  11. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2015 cited by 765

  12. Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)

    Authors: , , , , , , , , , , , , , - Oral Oncology 2017 cited by 290

  13. Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2022 cited by 107

  14. Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers

    Authors: , , , , , , , , , , , - Journal of Clinical Oncology 2010 cited by 503

  15. Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 cited by 245

  16. Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Suet-Ting Hung, Lin Wang, Ann Margaret V. Chang, Simion I. Chiosea, Matthew L. Hedberg, Sai‐Wah Tsao, Andrew C. van Hasselt, Anthony T.�C. Chan, Jennifer R. Grandis, Peter S. Hammerman, Kwok Wai Lo - Nature Communications 2017 cited by 334

  17. Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Trevor J. Pugh, Kwok Wai Lo - Nature Communications 2021 cited by 127

  18. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma.

    Authors: , , , , , , , , , - 1999 cited by 775

  19. Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein–Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients

    Authors: , , , , , , , , , , , , , - Cancer Research 2013 cited by 199

  20. A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer

    Authors: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2014 cited by 181

  21. Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma

    Authors: , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 cited by 176

  22. Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing

    Authors: , , , , , , , , , , , , - Clinical Chemistry 2012 cited by 489

  23. Recommendations for Epstein-Barr virus–based screening for nasopharyngeal cancer in high- and intermediate-risk regions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Su‐Mei Cao, Jun Ma, Anthony T.�C. Chan, K.C. Allen Chan, Allan Hildesheim - JNCI Journal of the National Cancer Institute 2023 cited by 45

  24. A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2005 cited by 589